Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 31: Measles commonly affects which age group?

A. 9 months to 3 years
B. 6 months to 2 years
C. 9 months to 2 years
D. 6 months to 3 years (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. 6 months to 3 years.** **1. Why Option D is Correct:** The age distribution of Measles is determined by the presence of maternal antibodies and the timing of vaccination. * **Lower Limit (6 months):** Infants are generally protected for the first 6 months of life by transplacental maternal antibodies (passive immunity). As these titers wane between 6 to 9 months, the child becomes susceptible. * **Upper Limit (3 years):** In endemic areas like India, measles is primarily a disease of early childhood. Most children are exposed to the virus or receive their first dose of the vaccine (at 9 months) and the second dose (at 16-24 months) by age 3, leading to population-wide immunity in older cohorts. **2. Why Other Options are Incorrect:** * **Options A & C (9 months):** While 9 months is the age for the first scheduled dose of the Measles vaccine in the National Immunization Schedule, susceptibility begins earlier (around 6 months) as maternal antibody levels drop below protective thresholds. * **Options B & C (2 years):** While many cases occur before age 2, the high-risk window extends up to 3 years, especially in areas with suboptimal vaccine coverage or high population density. **3. Clinical Pearls for NEET-PG:** * **Secondary Attack Rate (SAR):** Measles has a very high SAR (>80%), making it one of the most infectious diseases. * **Isolation:** The period of communicability is **4 days before to 4 days after** the appearance of the rash. * **Koplik’s Spots:** These are pathognomonic and appear on the buccal mucosa opposite the lower 2nd molars during the pre-eruptive stage. * **Vitamin A:** Supplementation is crucial in measles management to prevent complications like blindness and reduce mortality. * **Vaccination:** Under the UIP, Measles-Rubella (MR) vaccine is given at 9-12 months (1st dose) and 16-24 months (2nd dose).

Question 32: Teaching children about the side effects of taking drugs comes under which level of prevention?

A. Primary level of prevention
B. Secondary level of prevention
C. Tertiary level of prevention
D. Primordial prevention (Correct Answer)

Explanation: ### Explanation **1. Why Primordial Prevention is Correct:** Primordial prevention aims to prevent the **emergence or development of risk factors** in population groups where they have not yet appeared. In this scenario, children are a "clean slate" who have not yet developed the habit of drug use (the risk factor). By teaching them about the side effects of drugs, we are discouraging the adoption of harmful behaviors and lifestyles. The focus here is on **health education** to prevent the risk factor from ever establishing itself in the community. **2. Why Other Options are Incorrect:** * **Primary Prevention:** This involves action taken **prior to the onset of disease**, which removes the possibility that a disease will ever occur. It targets individuals who already have risk factors (e.g., using a condom to prevent HIV in a sexually active person). If the children were already exposed to environments where drug use was prevalent, interventions would shift toward primary prevention. * **Secondary Prevention:** This focuses on **early diagnosis and prompt treatment**. It aims to halt the progress of a disease in its incipient stage and prevent complications (e.g., screening tests). * **Tertiary Prevention:** This occurs when the disease has already caused significant damage. It focuses on **disability limitation and rehabilitation** (e.g., de-addiction centers for chronic drug users). **3. NEET-PG High-Yield Pearls:** * **Primordial vs. Primary:** If the question mentions "preventing the *emergence* of risk factors" or "changing social/environmental patterns," think **Primordial**. If it mentions "reducing the *impact* of existing risk factors" or "specific protection" (like vaccines), think **Primary**. * **Mode of Intervention:** The main intervention for Primordial prevention is **individual and mass education**. * **Classic Example:** Discouraging children from starting smoking to prevent future Ischemic Heart Disease (IHD) is the most frequently asked example of Primordial prevention.

Question 33: Which of the following methods can be used to eliminate bias in a study?

A. Matching
B. Blinding
C. Randomization
D. Multivariate analysis (Correct Answer)

Explanation: **Explanation:** In epidemiological studies, **Multivariate Analysis** is a statistical technique used during the **data analysis stage** to control for multiple variables simultaneously. It is the correct answer because it is a primary method used to eliminate **confounding bias** by mathematically adjusting for the effects of several independent variables on a single outcome. This allows researchers to isolate the true effect of the exposure being studied. **Analysis of Options:** * **Matching (Option A):** This is used during the **design stage** of a Case-Control study. While it eliminates confounding by ensuring equal distribution of known confounders between groups, it cannot eliminate bias arising from unknown variables and may lead to "over-matching." * **Blinding (Option B):** This technique is primarily used to eliminate **observer or participant bias** (subjectivity) in experimental studies. It does not address confounding or selection bias. * **Randomization (Option C):** Often called the "ideal" method, it is used in the **design stage** of Randomized Controlled Trials (RCTs). While it is the best method to distribute both known and unknown confounders equally, the question specifically points toward the analytical power of **Multivariate Analysis** as a tool to handle complex data sets where randomization might not have been possible (e.g., observational studies). **High-Yield Pearls for NEET-PG:** * **Methods to control confounding at the Design Stage:** Randomization, Restriction, and Matching. * **Methods to control confounding at the Analysis Stage:** Stratification and Multivariate Analysis (e.g., Logistic Regression, Cox Propensity Score). * **Randomization** is the only method that controls for **unknown** confounders. * **Blinding** reduces **Information/Measurement Bias**, not Confounding Bias.

Question 34: Which of the following conditions does not typically require chemoprophylaxis?

A. Typhoid
B. Chickenpox (Correct Answer)
C. Influenza
D. Cholera

Explanation: **Explanation:** The core concept of **chemoprophylaxis** involves the administration of specific drugs (including antibiotics and antivirals) to prevent the development of an infection in an exposed or high-risk individual. **Why Chickenpox (Option B) is the correct answer:** Chickenpox (Varicella-Zoster Virus) is primarily managed through **immunoprophylaxis** rather than chemoprophylaxis. Prevention post-exposure relies on the **Varicella vaccine** (within 3–5 days of exposure) or **Varicella-Zoster Immunoglobulin (VZIG)** for immunocompromised individuals. Antiviral drugs like Acyclovir are used for treatment or "pre-emptive therapy" in high-risk cases, but they are not routinely administered as standard chemoprophylaxis for the general population. **Analysis of Incorrect Options:** * **Typhoid (Option A):** While vaccination is the primary prevention, chemoprophylaxis (e.g., Ciprofloxacin or Azithromycin) may be indicated in specific outbreak settings or for household contacts in certain epidemiological contexts. * **Influenza (Option C):** Antiviral chemoprophylaxis with **Oseltamivir** (Tamiflu) or Zanamivir is a standard recommendation for high-risk individuals (e.g., nursing home residents) during an outbreak or post-exposure. * **Cholera (Option D):** Mass chemoprophylaxis is not recommended, but **selective chemoprophylaxis** (using Doxycycline or Tetracycline) is indicated for close household contacts to limit secondary transmission. **High-Yield NEET-PG Pearls:** * **Cholera:** Drug of choice for chemoprophylaxis is **Doxycycline** (single dose). * **Meningococcal Meningitis:** Drug of choice is **Rifampicin** (Ciprofloxacin or Ceftriaxone are alternatives). * **Leptospirosis:** Chemoprophylaxis for high-risk exposure is **Doxycycline** (200 mg weekly). * **Plague:** Chemoprophylaxis is done using **Tetracycline** or Doxycycline. * **Pertussis:** Erythromycin is used for household contacts.

Question 35: What does the risk ratio measure?

A. Relative risk (Correct Answer)
B. Attributable risk
C. Effectiveness of a population control trial
D. Odds ratio

Explanation: ### Explanation **Correct Answer: A. Relative Risk** The **Risk Ratio (RR)**, also known as **Relative Risk**, is the fundamental measure of association in **Cohort Studies**. It is defined as the ratio of the incidence of a disease among an exposed group to the incidence of the disease among a non-exposed group ($RR = \text{Incidence among exposed} / \text{Incidence among non-exposed}$). It measures the strength of the association between a suspected risk factor and the outcome. A value greater than 1 indicates a positive association (increased risk). **Why other options are incorrect:** * **B. Attributable Risk (AR):** This measures the amount of disease incidence that can be attributed to a specific exposure. It is calculated as the *difference* between the incidence in the exposed and non-exposed groups ($I_e - I_o$), rather than a ratio. It indicates the potential impact of public health interventions. * **C. Effectiveness of a trial:** While RR can be used in clinical trials (as Relative Risk Reduction), the term "Risk Ratio" specifically refers to the epidemiological measure of association. Effectiveness is more broadly measured by Efficacy rates and Number Needed to Treat (NNT). * **D. Odds Ratio (OR):** This is the measure of association used in **Case-Control studies**. It is the ratio of the odds of exposure among cases to the odds of exposure among controls. OR is an estimate of RR when the disease is rare. **High-Yield NEET-PG Pearls:** * **Cohort Study:** Starts with Cause $\rightarrow$ Effect. Measures **Incidence** and **Relative Risk**. * **Case-Control Study:** Starts with Effect $\rightarrow$ Cause. Measures **Odds Ratio**. * If **RR = 1**, there is no association between exposure and disease. * **Population Attributable Risk:** Useful for prioritizing public health resources as it shows how much of the disease can be eliminated from the *entire* population if the exposure is removed.

Question 36: Which of the following is considered primordial prevention?

A. Avoiding nicotine (Correct Answer)
B. Chemoprophylaxis
C. Vaccination
D. Screening

Explanation: **Explanation:** **Primordial prevention** is defined as the prevention of the emergence or development of risk factors in population groups where they have not yet appeared. It focuses on changing social, economic, and environmental patterns (e.g., lifestyle modification and health education) to prevent the "roots" of chronic diseases. 1. **Why "Avoiding Nicotine" is correct:** Smoking/nicotine is a major risk factor for non-communicable diseases (NCDs) like CAD and lung cancer. Encouraging a child or a population to never start using nicotine is the hallmark of primordial prevention—it stops the risk factor from ever developing. 2. **Why other options are incorrect:** * **Chemoprophylaxis (B) and Vaccination (C):** These are examples of **Primary Prevention**. Here, the risk factor (e.g., a pathogen or exposure) is already present, and the goal is to prevent the onset of disease through specific protection. * **Screening (D):** This is **Secondary Prevention**. Screening aims for early diagnosis and prompt treatment of a disease that has already started but is in the subclinical/asymptomatic stage. **High-Yield Clinical Pearls for NEET-PG:** * **Target Audience:** Primordial prevention is most effective when targeted at **children** to prevent the adoption of harmful habits. * **Disease Focus:** It is the mainstay for preventing **Non-Communicable Diseases (NCDs)** like obesity, hypertension, and cardiovascular diseases. * **Levels of Prevention Mnemonic:** * **Primordial:** Prevent *Risk Factor* development. * **Primary:** Action taken *before* the onset of disease (Vaccination). * **Secondary:** Action which *halts* the progress of disease (Screening/Pap smear). * **Tertiary:** Action taken to *limit disability* and provide rehabilitation (Physiotherapy).

Question 37: What is the estimated prevalence of HIV infection in antenatal women and in high-risk populations in a state classified as Group III?

A. Group I
B. Group II
C. Group III (Correct Answer)
D. Group IV

Explanation: ### Explanation The classification of HIV epidemic levels in India is based on the prevalence of HIV among specific population groups, primarily monitored through **Sentinel Surveillance**. This classification helps in prioritizing interventions and resource allocation. **The Correct Answer is Group III:** According to the National AIDS Control Organization (NACO) classification: * **Group III (Low Prevalence):** HIV prevalence is **<5% in all High-Risk Groups (HRGs)** (such as FSW, MSM, IDUs) AND **<1% in antenatal women** (the general population proxy) in all sites. This indicates the epidemic is still at a very low level and has not established a firm foothold even in high-risk groups. **Analysis of Incorrect Options:** * **Group I (High Prevalence):** HIV prevalence is **>1% in antenatal women** in all sites. This indicates a generalized epidemic where the virus is spreading in the general population. * **Group II (Moderate Prevalence):** HIV prevalence is **<1% in antenatal women** but **>5% in any High-Risk Group (HRG)**. This is a concentrated epidemic. * **Group IV:** This category is generally used for states with very low or highly fluctuating data where no clear trend is established, but it does not fit the specific prevalence criteria mentioned in the question. **High-Yield Clinical Pearls for NEET-PG:** * **Sentinel Surveillance:** The primary method used to monitor HIV trends in India. * **Proxy for General Population:** Antenatal Clinic (ANC) attendees are used as the surrogate group to estimate HIV prevalence in the general population. * **High-Risk Groups (HRGs):** Include Female Sex Workers (FSW), Men who have Sex with Men (MSM), and Injecting Drug Users (IDU). * **Current Trend:** India is currently moving towards a "Concentrated Epidemic" model, where the focus is heavily on HRGs to prevent spillover into the general population.

Question 38: What is the drug of choice for chemoprophylaxis in contacts of a patient with pneumonic plague?

A. Penicillin
B. Rifampicin
C. Erythromycin
D. Tetracycline (Correct Answer)

Explanation: **Explanation:** **Plague** is a zoonotic infection caused by *Yersinia pestis*. The pneumonic form is highly contagious and carries a high mortality rate, necessitating immediate chemoprophylaxis for close contacts (those within 2 meters of a patient). **1. Why Tetracycline is Correct:** **Tetracycline** (or Doxycycline) is the gold-standard drug of choice for chemoprophylaxis against plague. It is highly effective in preventing the progression of the disease in exposed individuals. The standard regimen is Tetracycline (500 mg four times daily) or Doxycycline (100 mg twice daily) for **7 days**. **2. Why Other Options are Incorrect:** * **Penicillin (A):** *Yersinia pestis* is naturally resistant to penicillins; they have no role in the treatment or prophylaxis of plague. * **Rifampicin (B):** This is primarily used for prophylaxis in Meningococcal meningitis and Leprosy, not for plague. * **Erythromycin (C):** While it has some activity against certain Gram-negative bacteria, it is significantly less effective than tetracyclines for *Y. pestis* and is not a recommended prophylactic agent. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Treatment:** **Streptomycin** is the traditional DOC for treating bubonic and pneumonic plague. Gentamicin is a common alternative. * **Alternative Prophylaxis:** In children under 8 years or pregnant women (where tetracyclines are contraindicated), **Sulfadiazine** or **Trimethoprim-Sulfamethoxazole** can be used. * **Vector:** The primary vector is the **Rat Flea (*Xenopsylla cheopis*)**. * **Quarantine:** The international quarantine period for Plague is **6 days**.

Question 39: Selection bias occurs mainly in which type of study?

A. Cohort study
B. Case-control study (Correct Answer)
C. Randomized controlled trial
D. All the above

Explanation: **Explanation:** **Selection bias** occurs when the study population does not accurately represent the target population due to the way participants are selected. **Why Case-Control Study is the correct answer:** In a case-control study, the researcher selects participants based on the **outcome** (presence or absence of disease) and then looks backward for exposure. This design is highly susceptible to selection bias because both the "cases" and "controls" are often chosen from hospital settings (Berkson’s bias) or through non-random methods. If the criteria for selecting cases differ systematically from those for selecting controls (other than the disease itself), the relationship between exposure and outcome becomes distorted. **Analysis of Incorrect Options:** * **Cohort Study:** While selection bias can occur (e.g., Healthy Worker Effect), these studies are more prone to **Follow-up bias (Attrition bias)** because they track participants over time. * **Randomized Controlled Trial (RCT):** The hallmark of an RCT is **Randomization**, which is specifically designed to eliminate selection bias by ensuring that every participant has an equal chance of being assigned to any group, thereby balancing both known and unknown confounders. * **All of the above:** While bias can exist in any study, it is "mainly" or most characteristically associated with Case-Control designs in epidemiological hierarchy. **High-Yield Clinical Pearls for NEET-PG:** * **Berkson’s Bias (Admission Rate Bias):** A specific type of selection bias occurring in hospital-based case-control studies. * **Neyman Bias (Prevalence-Incidence Bias):** Occurs when cases are selected from survivors (common in cross-sectional/case-control studies of fatal diseases). * **Recall Bias:** The most common type of **Information Bias** in case-control studies (not to be confused with selection bias). * **Gold Standard to eliminate Selection Bias:** Randomization.

Question 40: Which of the following is NOT true regarding consanguineous marriages and genetic abnormalities?

A. Increased risk of traits controlled by dominant genes (Correct Answer)
B. Increased risk of premature death
C. Phenylketonuria is an example of a condition seen
D. Lowering the incidence of consanguineous marriages will improve community health

Explanation: ### Explanation **1. Why Option A is the Correct Answer (The Medical Concept):** Consanguineous marriage (marriage between blood relatives) increases the risk of genetic disorders primarily through **autosomal recessive** inheritance, not dominant genes. When parents share a common ancestor, there is a significantly higher probability that both carry the same rare, recessive allele. When these two carriers mate, their offspring have a 25% chance of being homozygous for that allele, thus expressing the disease. **Dominant traits**, conversely, require only one copy of the gene to be expressed and are usually evident in the parent; their incidence does not specifically increase due to inbreeding. **2. Analysis of Incorrect Options:** * **Option B (Increased risk of premature death):** This is **true**. Consanguinity is associated with higher rates of "lethal equivalents," leading to increased risks of stillbirths, neonatal mortality, and infant mortality due to congenital malformations. * **Option C (Phenylketonuria):** This is **true**. PKU is a classic example of an autosomal recessive metabolic disorder. Other examples include Albinism, Alkaptonuria, and Tay-Sachs disease, all of which show increased prevalence in consanguineous populations. * **Option D (Lowering incidence improves health):** This is **true**. Reducing consanguinity (a form of primary prevention) decreases the "genetic load" of recessive diseases in a population, leading to a long-term improvement in community health indicators. **3. NEET-PG High-Yield Pearls:** * **Coefficient of Inbreeding (F):** Measures the probability that two genes at any locus in an individual are identical by descent. For first cousins, $F = 1/16$. * **Genetic Burden:** Consanguinity does not create new mutations; it simply brings existing "hidden" recessive genes into a homozygous state (expression). * **Most Common Risk:** The most common clinical outcomes of consanguinity are congenital heart defects, blindness, deafness, and intellectual disabilities.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free